Alpha Cognition Inc (TSE:ACOG) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Alpha Cognition Inc. has announced the partial exercise of its over-allotment option, resulting in the sale of an additional 488,506 shares at $5.75 per share, raising an extra $2.8 million in gross proceeds. In total, the company sold over 9 million shares, generating approximately $52.8 million to support the commercialization of its Alzheimer’s drug ZUNVEYL and further research. The shares, trading under the ticker ACOG on Nasdaq, aim to bolster the company’s resources for advancing its neurodegenerative treatment pipeline.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.